L-.GAMMA.-GLUTAMYL-S-((4S)-4-(CYCLOPROPYLETHYNYL)-5-FLUORO-1,2,3,4-TETRAHYDRO-6-HYDROXY-2-OXO-4-(TRIFLUOROMETHYL)-7-QUINAZOLINYL)-L-CYSTEINYL-GLYCINE
UNII 8F6OWE6BHP
Substance Identification & Data
This profile provides standardized clinical and technical data for L-.gamma.-glutamyl-s-((4s)-4-(cyclopropylethynyl)-5-fluoro-1,2,3,4-tetrahydro-6-hydroxy-2-oxo-4-(trifluoromethyl)-7-quinazolinyl)-l-cysteinyl-glycine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8F6OWE6BHP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 410090-43-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H25F4N5O8S JWIYRJGTRFKLID-HNDXJFMUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for L-.gamma.-glutamyl-s-((4s)-4-(cyclopropylethynyl)-5-fluoro-1,2,3,4-tetrahydro-6-hydroxy-2-oxo-4-(trifluoromethyl)-7-quinazolinyl)-l-cysteinyl-glycine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.